Rivaban 20 Tablet

About Rivaban 20 Tablet

Rivaban 20 is a tablet containing rivaroxaban 20 mg, an oral anticoagulant. It is used in adults to lower the risk of harmful blood clots in certain heart and blood vessel conditions.

There are 19 brands of Rivaroxaban listed in Bangladesh. The lowest listed price is Rivadel 2.5 Tablet at ৳ 5 per unit.

What is Rivaban 20 Tablet?

Rivaban 20 is a 20 mg tablet made by Advanced Chemical Industries PLC. Its active ingredient, rivaroxaban, belongs to a group of medicines called oral anticoagulants. It works by blocking a clotting protein called factor Xa, which helps to slow down the blood clotting process. Doctors prescribe it in adults for particular heart and blood vessel conditions where clots are a concern. Because it affects clotting, bleeding is the main risk to be aware of. The doctor decides the dose and how long it should be taken, and regular follow-up is important.

Uses of Rivaban 20

Rivaban 20 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism. It is an oral anticoagulant, sometimes called a blood thinner. Whether it suits a particular person depends on their condition and medical history, so the doctor decides if it is appropriate.

How to use Rivaban 20

Take Rivaban 20 exactly as the doctor tells you. The tablet is swallowed, and the doctor will say whether to take it with food and at what time of day. Do not change the amount or stop taking it on your own, because stopping suddenly can raise the risk of clots. If you miss a dose, ask the doctor or pharmacist what to do rather than doubling up.

Side effects of Rivaban 20

The most common side effect is a greater chance of bleeding, which can include bruising, nosebleeds or longer bleeding from small cuts. Bleeding around the spine or in the space around the spinal cord (spinal or epidural hematoma) can occur. In people with nonvalvular atrial fibrillation, stopping the medicine has been linked to an increased risk of stroke. Call the doctor promptly if you notice unusual or lasting bleeding.

Safety and precautions

Tell the doctor about any bleeding disorder, uncontrolled severe high blood pressure, stomach or bowel disease, eye vessel problems, bronchiectasis or a history of bleeding in the lungs before starting Rivaban 20, as these raise the risk of serious bleeding. Do not stop the medicine without the doctor's advice, since stopping early can increase the risk of clots. It is a pregnancy category C medicine, and its use in pregnancy and breastfeeding has not been established, so pregnant or breastfeeding women should speak to the doctor first. Ask the doctor about precautions before any surgery or spinal procedure.

Frequently asked questions

What kind of medicine is Rivaban 20 and what is it used for?

It is a 20 mg rivaroxaban tablet, an oral anticoagulant. Doctors use it in adults to reduce the risk of stroke and systemic embolism in nonvalvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. The doctor decides whether it is suitable for you.

Which medicines may interact with Rivaban 20?

Some antifungal, HIV, antibiotic and heart medicines (such as ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil and dronedarone) should be avoided with it. Rifampicin, phenytoin and carbamazepine can lower its effect. Anti-platelet agents, heparin, clot-dissolving therapy and NSAIDs can raise bleeding risk. Tell the doctor or pharmacist about every medicine you take.

What side effects should I watch for, and when should I call the doctor?

Watch for increased bleeding, such as bruising, nosebleeds or bleeding that does not stop, and for bleeding around the spine after a spinal or epidural procedure. Call the doctor promptly if you notice unusual or lasting bleeding, or if you feel unwell after stopping the medicine.

Can I stop taking Rivaban 20 on my own?

No. Stopping it early without another anticoagulant raises the risk of blood clots, and in nonvalvular atrial fibrillation stopping has been linked to an increased risk of stroke. Always ask the doctor before stopping or changing it.

Indications

Rivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg ... Read moreRivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg:
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
  • For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery

Pharmacology

Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

Dosage & Administration

Rivaroxaban 2.5 mg:
  • The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
Rivaroxaban 10-20 mg:
  • Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
  • Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
  • Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
  • Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
  • Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
May be taken with or without food.

Interaction

Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.

Contraindications

It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.

Side Effects

The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.

Pregnancy & Lactation

Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.

Precautions & Warnings

Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.

Overdose Effects

Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.

Storage Conditions

Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.

Alternative brands of Rivaroxaban

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.